Anaphylactic response to factor IX replacement therapy in haemophilia B patients: Complete gene deletions confer the highest risk

E. C. Thorland, J. B. Drost, J. M. Lusher, I. Warrier, A. Shapiro, M. A. Koerper, D. Dimichele, J. Westman, N. S. Key, S. S. Sommer

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Anaphylactic response to factor IX replacement therapy in haemophilia B patients: Complete gene deletions confer the highest risk'. Together they form a unique fingerprint.

Medicine & Life Sciences